FTAI Aviation Ltd. USDC – Southern District of New York January 22, 2025 CLASS PERIOD: february 27, 2024 – december 19, 2024LEAD PLAINTIFF DEADLINE: march 18, 2025 Please complete the form below to contact Kaplan Fox regarding the FTAI Aviation Ltd. Investigation: Join a Case First Name * Last Name * Email Address * Phone Number * Ticker Symbol Or Company Name * Please Insert Your Estimation Of Losses In USD * Are you a current or former employee of the company mentioned having traded above? * Yes No Captcha Submit If you are human, leave this field blank. Principle Contacts Pamela MayerPMayer@kaplanfox.comLaurence D. KingLKing@kaplanfox.com Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against FTAI Aviation Ltd. (FTAI) – Deadline is March 18, 2025 Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against FTAI Aviation Ltd. (“FTAI Aviation” or the “Company”) (NASDAQ: FTAI) on behalf of investors that purchased or otherwise acquired FTAI Aviation securities between July 23, 2024 and January 15, 2025 (the “Class Period”). CLICK HERE TO JOIN THE CASE If you are an investor in FTAI Aviation and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing pmayer@kaplanfox.com or by calling (646) 315-9003. DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than March 18, 2025 to serve as a lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process. On January 15, 2025, Muddy Waters Research published a report entitled, “FTAI Aviation: Financial Engineering and Accounting Manipulation in the MRO Business” (“the Short-Seller Report”). Among other things, the Short-Seller Report alleges that “FTAI materially manipulates its financials” by “exaggerating the size of its aftermarket aerospace business,” “presenting whole engine sales as individual module sales,” “inflating Aerospace Products’ EBITDA margins by means of over-depreciation in the leasing segment,” and “engaging in channel stuffing.” On January 15, 2025, the price of FTAI Aviation stock fell $37.21 per share, over 24%, to close at $116.08 per share. Then, on January 21, 2025, FTAI Aviation announced in an 8-K filing with the Securities and Exchange Commission that the Audit Committee of the Board of Directors “determined to commence a review in response to the assertions alleged” in the Short-Seller Report. The Company further advised that “the Company cannot rule out the possibility that the filing of the Company’s Annual Report on Form 10-K for fiscal year 2024 may be delayed.” On January 21, 2025, the price of FTAI Aviation stock fell $28.59 per share, over 25%, to close at $83.79 per share. WHY CONTACT KAPLAN FOX Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. If you have any questions about this Notice, your rights, or your interests, please contact: CONTACT: Pamela A. MayerKAPLAN FOX & KILSHEIMER LLP800 Third Avenue, 38th FloorNew York, New York 10022(646) 315-9003pmayer@kaplanfox.com Laurence D. KingKAPLAN FOX & KILSHEIMER LLP1999 Harrison Street, Suite 1560Oakland, California 94612(415) 772-4704lking@kaplanfox.com Connect with Kaplan Fox. Receive a complimentary case review now. Contact Us FTAI Aviation Ltd. See the Case Innovative Industrial Properties, Inc. See the Case AstraZeneca PLC See the Case TransMedics Group, Inc. See the Case Nextracker Inc. See the Case Revance Therapeutics, Inc. See the Case Carvana Co. See the Case MGP Ingredients, Inc. See the Case Dave & Busters Entertainment, Inc. See the Case Celsius Holdings, Inc. See the Case Dentsply Sirona Inc. See the Case Western Asset Macro Opportunities Fund See the Case